drugset
drugset / Trial / NCT05827042

Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion

NCT05827042 ↗

Phase 3 Recruiting 338 enrolled The First Affiliated Hospital of University of Science and Technology of China
RandomizedParallel-groupSingle-blindTreatment

Summary

To assess the effect of endovascular thrombectomy alone compared to intravenous thrombolysis plus endovascular thrombectomy in acute basilar artery occlusion patients within 4.5 hours from onset on efficacy and safety outcomes.

Timeline

Start
2023-05-09
Primary completion
2026-06-30
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alteplase Protein / enzyme biologic 0.9 mg/kg Intravenous
Comparator Tenecteplase Protein / enzyme biologic 0.25 mg/kg Intravenous

Indications

basilar artery occlusion stroke disorder